FREQUENCY OF SUCCESSFUL VAGINAL DELIVERY IN GESTATIONAL DIABETES MELLITUS PATIENTS INDUCED WITH PROSTAGLANDIN E2 AT TERM
DOI:
https://doi.org/10.71000/m1j8cb49Keywords:
Prostglandin E2, Body Mass Index, Cesarean Section, Gestational Age, Gestational Diabetes Mellitus, Labor Induction, Vaginal DeliveryAbstract
Background: Gestational diabetes mellitus (GDM) is a rising concern in obstetric care due to its association with adverse maternal and fetal outcomes. Timely and effective labor induction strategies are critical to optimize delivery outcomes in these patients. Prostaglandin E2 (PGE2) is commonly employed for cervical ripening, yet its success in women with GDM remains variably reported. Identifying clinical predictors of successful vaginal delivery following induction can help guide patient management.
Objective: To determine the frequency of successful vaginal delivery in women with GDM induced with Prostaglandin E2 at term and to assess the influence of maternal characteristics on delivery outcomes.
Methods: This cross-sectional study was conducted at the Department of Obstetrics and Gynecology, CMH Kohat, from December 3, 2023, to June 2, 2024. A total of 135 women aged 18–40 years with singleton pregnancies beyond 36 weeks gestation and diagnosed with GDM were enrolled through non-probability consecutive sampling. Induction of labor was performed using 2 mg vaginal PGE2 gel every 12 hours, up to a maximum of three doses. Successful vaginal delivery (SVD) was defined as delivery within 24 hours of induction without surgical intervention. Data were analyzed using SPSS version 26.
Results: The mean age and BMI of participants were 30.44 ± 5.54 years and 23.91 ± 2.51 kg/m², respectively. Of the 135 women, 103 (76.3%) achieved successful vaginal delivery. Significant associations were found between SVD and BMI (p = 0.001), as well as GDM duration (p = 0.007). No significant association was observed with maternal age, parity, or gestational age.
Conclusion: Prostaglandin E2 is an effective agent for inducing labor in women with GDM. Lower BMI and shorter GDM duration appear to favor successful vaginal delivery.
References
Wang H, Li N, Chivese T, Werfalli M, Sun H, Yuen L, et al. IDF diabetes atlas: estimation of global and regional gestational diabetes mellitus prevalence for 2021 by international association of diabetes in pregnancy study group’s criteria. Diabetes Res Clin Pract. 2022; 183:109050.
Kondracki AJ, Valente MJ, Ibrahimou B, Bursac Z. Risk of large for gestational age births at early, full and late term in relation to pre-pregnancy body mass index: mediation by gestational diabetes status. Paediatr Perinat Epidemiol. 2022;36(4):566-76.
Oliveira MM, Andrade KFO, Lima GHS, Rocha TC. Metformin versus glyburide in treatment and control of gestational diabetes mellitus: a systematic review with meta-analysis. Einstein. 2022;20: eRW6155.
Wood EM, Hornaday KK, Slater DM. Prostaglandins in biofluids in pregnancy and labour: a systematic review. PLoS One. 2021;16(11): e0260115.
Bouchghoul H, Zeino S, Houllier M, Senat MV. Cervical ripening by prostaglandin E2 in patients with a previous cesarean section. J Gynecol Obstet Hum Reprod. 2020;49(4):101699.
Yannie YY, Tsz-Kin LO, Ellen LM, Lai-Fong HO. Indications for induction of labour and mode of delivery in nulliparous term women with an unfavourable cervix. Hong Kong Journal of Gynaecology, Obstetrics and Midwifery. 2021;21(2).
Gaudineau A, Senat MV, Ehlinger V, Gallini A, Morin M, Olivier P, Roth E, Orusco E, Javoise S, Fort J, Lavergne C. Induction of labor at term with vaginal misoprostol or a prostaglandin E2 pessary: a noninferiority randomized controlled trial. American Journal of Obstetrics and Gynecology. 2021 Nov 1;225(5):542-e1.
Vince K, Matijević R. Comparison of intracervical and intravaginal prostaglandin E2 for induction of labor in term pregnancies with unfavorable cervix: Randomized controlled trial. European Journal of Obstetrics & Gynecology and Reproductive Biology. 2022 Mar 1; 270:100-4.
Takizawa A, Tsunoda Y, Matsushima T, Suzuki S. Factors associated with insufficient cervical ripening in a controlled-release dinoprostone vaginal delivery system: A single perinatal center retrospective study. Taiwanese Journal of Obstetrics and Gynecology. 2024 Nov 1;63(6):887-91.
Liu W, Guo L, Feng L, Wang J, Zhang M, Fan X. Predictive Factors for the Success of Vaginal Dinoprostone for the Induction of Labour. International Journal of Women's Health. 2024 Dec 31:1093-101.
OuYang H, Chen B, Abdulrahman AM, Li L, Wu N. Associations between Gestational Diabetes and Anxiety or Depression: A Systematic Review. J Diabetes Res. 2021;2021:9959779.
Sweeting A, Wong J, Murphy HR, Ross GP. A Clinical Update on Gestational Diabetes Mellitus. Endocr Rev. 2022;43(5):763-93.
Sharma AK, Singh S, Singh H, Mahajan D, Kolli P, Mandadapu G, et al. Deep Insight of the Pathophysiology of Gestational Diabetes Mellitus. Cells. 2022;11(17).
Mohan S, Egan AM. Diagnosis and Treatment of Hyperglycemia in Pregnancy: Type 2 Diabetes Mellitus and Gestational Diabetes. Endocrinol Metab Clin North Am. 2024;53(3):335-47.
Rasmussen L, Poulsen CW, Kampmann U, Smedegaard SB, Ovesen PG, Fuglsang J. Diet and Healthy Lifestyle in the Management of Gestational Diabetes Mellitus. Nutrients. 2020;12(10).
Moholdt T. Diet, Exercise and Gestational Diabetes Mellitus. Nutrients. 2023;15(10).
Mistry SK, Das Gupta R, Alam S, Kaur K, Shamim AA, Puthussery S. Gestational diabetes mellitus (GDM) and adverse pregnancy outcome in South Asia: A systematic review. Endocrinol Diabetes Metab. 2021;4(4):e00285.
Chatzakis C, Cavoretto P, Sotiriadis A. Gestational Diabetes Mellitus Pharmacological Prevention and Treatment. Curr Pharm Des. 2021;27(36):3833-40.
Modzelewski R, Stefanowicz-Rutkowska MM, Matuszewski W, Bandurska-Stankiewicz EM. Gestational Diabetes Mellitus-Recent Literature Review. J Clin Med. 2022;11(19).
Alejandro EU, Mamerto TP, Chung G, Villavieja A, Gaus NL, Morgan E, et al. Gestational Diabetes Mellitus: A Harbinger of the Vicious Cycle of Diabetes. Int J Mol Sci. 2020;21(14).
Wei X, Zou H, Zhang T, Huo Y, Yang J, Wang Z, et al. Gestational Diabetes Mellitus: What Can Medical Nutrition Therapy Do? Nutrients. 2024;16(8).
Lu W, Hu C. Molecular biomarkers for gestational diabetes mellitus and postpartum diabetes. Chin Med J (Engl). 2022;135(16):1940-51.
Juan J, Yang H. Prevalence, Prevention, and Lifestyle Intervention of Gestational Diabetes Mellitus in China. Int J Environ Res Public Health. 2020;17(24).
Yang Y, Guo F, Peng Y, Chen R, Zhou W, Wang H, et al. Transcriptomic Profiling of Human Placenta in Gestational Diabetes Mellitus at the Single-Cell Level. Front Endocrinol (Lausanne). 2021;12:679582.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Aeman Ameen, Syeda Surayya Jabeen, Raahima Nasim, Faria Mumtaz (Author)
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
